# Creative Medical Technology Holdings, Inc.: filings

CELZ · Nasdaq · CIK 1187953 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/celz.md) · [Financials](/companies/celz/financials.md) · [Filings](/companies/celz/filings.md) · [Insiders](/companies/celz/insiders.md)

## Reports and events: 215 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 105, 10-Q 53, 4 52, 10-K 18, D 17, CORRESP 15, UPLOAD 14, 3 10, 10-K/A 9, EFFECT 9, DEF 14A 8, 3/A 6, 424B3 6, SC 13G 6, 10-Q/A 5, DEF 14C 5, PRE 14A 5, PRE 14C 5, S-1 5, S-3 5, SC 13G/A 5, S-1/A 4, SC 13D/A 4, NT 10-Q 3, 144 2, 4/A 2, 8-K/A 2, DRS 2, DRS/A 2, NT 10-K 2, RW 2, 424B4 1, 424B5 1, 8-A12B 1, CERT 1, CT ORDER 1, DEFR14C 1, DRSLTR 1, POS AM 1, PRER14A 1, PRER14C 1, SC 13D 1, SC 14F1 1, SCHEDULE 13D 1, SCHEDULE 13G 1, SCHEDULE 13G/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-01 | 21:00 ET | [SCHEDULE 13D](/filings/0001477932-26-005959.md) | Ownership report, active investor | 0001477932-26-005959 |
| 2026-09-25 | 21:00 ET | [8-K](/filings/0001477932-26-005805.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001477932-26-005805 |
| 2026-08-31 | 20:05 ET | [8-K](/filings/0001477932-26-005329.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001477932-26-005329 |
| 2026-08-07 | 21:23 ET | [10-Q](/filings/0001477932-26-004779.md) | Quarterly report, period 2026-06-30 | 0001477932-26-004779 |
| 2026-07-14 | 20:00 ET | [DEF 14A](/filings/0001477932-26-004302.md) | Proxy statement, period 2026-08-28 | 0001477932-26-004302 |
| 2026-07-02 | 20:15 ET | [8-K](/filings/0001477932-26-004165.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001477932-26-004165 |
| 2026-06-26 | 20:16 ET | [S-1/A](/filings/0001477932-26-004044.md) | Registration statement, amended | 0001477932-26-004044 |
| 2026-06-25 | 20:06 ET | [S-1](/filings/0001477932-26-004010.md) | Registration statement | 0001477932-26-004010 |
| 2026-05-08 | 20:45 ET | [10-Q](/filings/0001477932-26-002893.md) | Quarterly report, period 2026-03-31 | 0001477932-26-002893 |
| 2026-04-24 | 20:45 ET | [10-K/A](/filings/0001477932-26-002534.md) | Annual report, amended, period 2025-12-31 | 0001477932-26-002534 |
| 2026-03-20 | 20:45 ET | [10-K](/filings/0001477932-26-001517.md) | Annual report, period 2025-12-31 | 0001477932-26-001517 |
| 2025-12-31 | 21:05 ET | [8-K](/filings/0001477932-25-009277.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001477932-25-009277 |
| 2025-12-19 | 21:01 ET | [8-K](/filings/0001477932-25-009094.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001477932-25-009094 |
| 2025-11-13 | 21:51 ET | [DEF 14A](/filings/0001477932-25-008184.md) | Proxy statement, period 2025-12-26 | 0001477932-25-008184 |
| 2025-11-12 | 11:12 ET | [8-K](/filings/0001477932-25-008027.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001477932-25-008027 |
| 2025-11-07 | 21:46 ET | [10-Q](/filings/0001477932-25-007978.md) | Quarterly report, period 2025-09-30 | 0001477932-25-007978 |
| 2025-10-31 | 20:05 ET | [8-K](/filings/0001477932-25-007849.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001477932-25-007849 |
| 2025-10-30 | 10:11 ET | [DEF 14A](/filings/0001477932-25-007803.md) | Proxy statement, period 2025-10-27 | 0001477932-25-007803 |
| 2025-08-08 | 20:45 ET | [10-Q](/filings/0001477932-25-005614.md) | Quarterly report, period 2025-06-30 | 0001477932-25-005614 |
| 2025-05-09 | 20:45 ET | [10-Q](/filings/0001477932-25-003498.md) | Quarterly report, period 2025-03-31 | 0001477932-25-003498 |
| 2025-05-06 | 20:30 ET | [8-K](/filings/0001477932-25-003370.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001477932-25-003370 |
| 2025-04-25 | 20:45 ET | [10-K/A](/filings/0001477932-25-002984.md) | Annual report, amended, period 2024-12-31 | 0001477932-25-002984 |
| 2025-04-11 | 21:00 ET | [8-K](/filings/0001477932-25-002645.md) | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001477932-25-002645 |
| 2025-04-04 | 21:00 ET | [10-K/A](/filings/0001477932-25-002473.md) | Annual report, amended, period 2024-12-31 | 0001477932-25-002473 |
| 2025-03-19 | 21:04 ET | [10-K/A](/filings/0001477932-25-001847.md) | Annual report, amended, period 2024-12-31 | 0001477932-25-001847 |
| 2025-03-17 | 20:01 ET | [DEF 14A](/filings/0001477932-25-001759.md) | Proxy statement, period 2025-03-19 | 0001477932-25-001759 |
| 2025-03-14 | 20:35 ET | [8-K](/filings/0001477932-25-001737.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001477932-25-001737 |
| 2025-03-14 | 20:30 ET | [10-K](/filings/0001477932-25-001736.md) | Annual report, period 2024-12-31 | 0001477932-25-001736 |
| 2025-03-07 | 21:05 ET | [8-K](/filings/0001477932-25-001537.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001477932-25-001537 |
| 2024-12-26 | 22:00 ET | [8-K](/filings/0001477932-24-008314.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001477932-24-008314 |
| 2024-11-08 | 21:45 ET | [10-Q](/filings/0001477932-24-006991.md) | Quarterly report, period 2024-09-30 | 0001477932-24-006991 |
| 2024-11-08 | 21:06 ET | [S-1](/filings/0001477932-24-006986.md) | Registration statement | 0001477932-24-006986 |
| 2024-11-04 | 21:01 ET | [DEF 14A](/filings/0001477932-24-006871.md) | Proxy statement, period 2024-12-19 | 0001477932-24-006871 |
| 2024-10-23 | 20:23 ET | [8-K](/filings/0001477932-24-006644.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001477932-24-006644 |
| 2024-08-09 | 20:45 ET | [10-Q](/filings/0001477932-24-004635.md) | Quarterly report, period 2024-06-30 | 0001477932-24-004635 |
| 2024-07-25 | 20:10 ET | [8-K](/filings/0001477932-24-004377.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001477932-24-004377 |
| 2024-06-05 | 20:05 ET | [DEF 14A](/filings/0001477932-24-003511.md) | Proxy statement, period 2024-07-19 | 0001477932-24-003511 |
| 2024-05-17 | 20:02 ET | [8-K](/filings/0001477932-24-003116.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 5.08 Item not in the standard list; 9.01 Financial statements and exhibits | 0001477932-24-003116 |
| 2024-05-10 | 20:45 ET | [10-Q](/filings/0001477932-24-002695.md) | Quarterly report, period 2024-03-31 | 0001477932-24-002695 |
| 2024-04-29 | 20:45 ET | [10-K/A](/filings/0001477932-24-002384.md) | Annual report, amended, period 2023-12-31 | 0001477932-24-002384 |
| 2024-03-22 | 20:45 ET | [10-K](/filings/0001477932-24-001431.md) | Annual report, period 2023-12-31 | 0001477932-24-001431 |
| 2023-12-20 | 21:05 ET | [8-K](/filings/0001477932-23-009261.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001477932-23-009261 |
| 2023-11-14 | 21:45 ET | [10-Q](/filings/0001477932-23-008458.md) | Quarterly report, period 2023-09-30 | 0001477932-23-008458 |
| 2023-11-03 | 20:05 ET | [DEF 14A](/filings/0001477932-23-008079.md) | Proxy statement, period 2023-10-31 | 0001477932-23-008079 |
| 2023-08-11 | 20:45 ET | [10-Q](/filings/0001477932-23-005935.md) | Quarterly report, period 2023-06-30 | 0001477932-23-005935 |
| 2023-06-28 | 13:00 ET | [8-K](/filings/0001477932-23-004849.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001477932-23-004849 |
| 2023-06-09 | 20:15 ET | [8-K](/filings/0001477932-23-004441.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001477932-23-004441 |
| 2023-05-12 | 20:30 ET | [10-Q](/filings/0001477932-23-003347.md) | Quarterly report, period 2023-03-31 | 0001477932-23-003347 |
| 2023-05-01 | 20:45 ET | [10-K/A](/filings/0001477932-23-003013.md) | Annual report, amended, period 2022-12-31 | 0001477932-23-003013 |
| 2023-03-31 | 20:46 ET | [10-K](/filings/0001477932-23-002123.md) | Annual report, period 2022-12-31 | 0001477932-23-002123 |

Page 1 of 5. [Older](/companies/celz/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:10 ET. No prices; not investment advice.